Crinetics Pharmaceuticals (CRNX) Return on Sales [ROS] (2017 - 2026)
Crinetics Pharmaceuticals (CRNX) recorded Return on Sales [ROS] of -527.35% in Q2 2026, up 11995.64 percentage points from -12522.99% a year earlier and up 780.44 percentage points from the prior quarter.
Crinetics Pharmaceuticals (CRNX) Return on Sales [ROS] (2017 - 2026) Analysis & Trends
On a TTM basis, Crinetics Pharmaceuticals' Return on Sales [ROS] came in at -1302.52% as of Jun 30, 2026, up 29089.65 percentage points year-over-year; for FY2025, it came in at -6714.77%, up 25898.70 percentage points from FY2024.
- Annual Return on Sales [ROS] has a five-year change of +98852.83 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -32613.47% in FY2024 (-27066.30 pp), -5547.17% in FY2023 (-2003.11 pp), -3544.06% in FY2022 (+6446.85 pp) and -9990.91% in FY2021 (+95576.70 pp).
- The Q2 2026 figure is the highest quarterly Return on Sales [ROS] since Q4 2017.
- On a year-over-year basis, Return on Sales [ROS] has increased for three consecutive quarters, with an average year-over-year change of -6110.76 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 102702.30 percentage points in Q4 2021, against a drop of 70185.27 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -1307.79% (Q1 2026), -2169.55% (Q4 2025) and -99710.49% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | -527.35% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -527.35% |
| Mar 31, 2026 | -1,307.79% |
| Dec 31, 2025 | -2,169.55% |
| Sep 30, 2025 | -99,710.49% |
| Jun 30, 2025 | -12,522.99% |
| Mar 31, 2025 | -30,860.11% |
| Dec 31, 2024 | -32,613.47% |
| Sep 30, 2024 | -29,525.22% |
| Jun 30, 2024 | -20,747.62% |
| Mar 31, 2024 | -11,488.91% |
| Dec 31, 2023 | -5,547.17% |
| Sep 30, 2023 | -17,045.38% |
| Jun 30, 2023 | -5,363.87% |
| Mar 31, 2023 | -1,790.89% |
| Dec 31, 2022 | -6,707.48% |
| Sep 30, 2022 | -9,487.77% |
| Jun 30, 2022 | -9,805.24% |
| Mar 31, 2022 | -1,080.39% |
| Dec 31, 2021 | -2,865.31% |
| Dec 31, 2020 | -105,567.61% |
Crinetics Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CRNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();